Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT03685344
Title Safety and Antitumor Activity Study of Loncastuximab Tesirine and Durvalumab in Diffuse Large B-Cell, Mantle Cell, or Follicular Lymphoma
Recruitment Terminated
Gender both
Phase Phase I
Variant Requirements No
Sponsors ADC Therapeutics S.A.

mantle cell lymphoma

diffuse large B-cell lymphoma

follicular lymphoma


Durvalumab + Loncastuximab tesirine-lpyl

Age Groups: adult | senior
Covered Countries USA | ESP

Facility Status City State Zip Country Details
University of Alabama at Birmingham Birmingham Alabama 35294 United States Details
UCH-MHS Memorial Hospital Centeral Colorado Springs Colorado 80909 United States Details
University of Florida Health Shands Cancer Hospital Gainesville Florida 32603 United States Details
University of Miami - Sylvester Comprehensive Cancer Center Miami Florida 33136 United States Details
Rutgers Cancer Institute of New Jersey New Brunswick New Jersey 08901 United States Details
Icahm School of Medicine at Mount Sinai New York New York 10029 United States Details
Baylor University Medical Center Dallas Texas 75246 United States Details
Joe Arrington Cancer Research and Treatment Center Lubbock Texas 79410 United States Details
Baylor Scott & White Medical Center - Temple Temple Texas 76508 United States Details
Hospital Clinic de Barcelona Barcelona 08036 Spain Details
Hospital General Universitario Gregorio Marañon Pabellón de Oncología Madrid 28009 Spain Details
Hospital Universitario Fundación Jiménez Díaz Unidad de Limfomas Servicio de Hematologia Madrid 28040 Spain Details
Hospital Universitario Virgen Macarena Servicio Oncologia Medica Sevilla 41009 Spain Details
Hospital Universitario Virgen Del Rocio Sevilla 41015 Spain Details
*Shaded cells indicate that there was no data available from for the field